<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>ABBV on Market Pulse</title>
    <link>https://mktpulse.pages.dev/tags/abbv/</link>
    <description>Recent content in ABBV on Market Pulse</description>
    <generator>Hugo</generator>
    <language>en</language>
    <lastBuildDate>Mon, 22 Jun 2026 00:00:00 +0000</lastBuildDate>
    <atom:link href="https://mktpulse.pages.dev/tags/abbv/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Market Briefing — 2026-06-22</title>
      <link>https://mktpulse.pages.dev/briefings/2026-06-22/</link>
      <pubDate>Mon, 22 Jun 2026 00:00:00 +0000</pubDate>
      <guid>https://mktpulse.pages.dev/briefings/2026-06-22/</guid>
      <description>The market is navigating a complex landscape defined by sector-specific strength and mounting systemic risks. Bullish sentiment is fueled by a hot pharma M&amp;amp;A market, led by &lt;strong&gt;AbbVie&amp;rsquo;s&lt;/strong&gt; $10.9B deal for &lt;strong&gt;Apogee&lt;/strong&gt;, and massive hype around the upcoming &lt;strong&gt;SpaceX&lt;/strong&gt; IPO. However, this optimism is tempere</description>
    </item>
  </channel>
</rss>
